Horizon Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$915K Buy
14,563
+196
+1% +$13.6K 0.01% 677
2025
Q4
$954K Buy
14,367
+2,043
+17% +$132K 0.01% 643
2025
Q3
$829K Sell
12,324
-635
-5% -$50.3K 0.01% 666
2025
Q2
$1.13M Buy
12,959
+7,351
+131% +$576K 0.02% 538
2025
Q1
$383K Buy
5,608
+123
+2% +$10K 0.01% 418
2024
Q4
$427K Buy
5,485
+46
+0.8% +$3.41K 0.01% 400
2024
Q3
$365K Sell
5,439
-411
-7% -$33.8K 0.01% 411
2024
Q2
$663K Buy
5,850
+600
+11% +$75.9K 0.02% 320
2024
Q1
$728K Sell
5,250
-196
-4% -$24.6K 0.02% 298
2023
Q4
$676K Sell
5,446
-3,083
-36% -$315K 0.02% 286
2023
Q3
$796K Sell
8,529
-20
-0.2% -$2.25K 0.02% 206
2023
Q2
$1.1M Buy
8,549
+591
+7% +$71.5K 0.03% 176
2023
Q1
$925K Sell
7,958
-1,376
-15% -$154K 0.03% 189
2022
Q4
$1.06M Buy
9,334
+2,587
+38% +$284K 0.03% 212
2022
Q3
$543K Buy
6,747
+351
+5% +$29.7K 0.02% 310
2022
Q2
$477K Buy
6,396
+632
+11% +$57.7K 0.02% 293
2022
Q1
$737K Sell
5,764
-6,032
-51% -$660K 0.02% 278
2021
Q4
$1.58M Buy
11,796
+888
+8% +$128K 0.05% 166
2021
Q3
$1.49M Sell
10,908
-608
-5% -$76.7K 0.04% 175
2021
Q2
$1.23M Buy
11,516
+8,216
+249% +$789K 0.04% 186
2021
Q1
$296K Sell
3,300
-136
-4% -$12.8K 0.01% 374
2020
Q4
$318K Buy
+3,436
New +$307K 0.36% 73
2020
Q3
Sell
-2,456
Closed -$249K 399
2020
Q2
$249K Buy
+2,456
New +$220K 0.01% 399

Other funds holding DXCM

Horizon Investments's DXCM Position: Q1 2026 in Review

Horizon Investments increased its DexCom (DXCM) stake by 1.4% in Q1 2026, buying an estimated $13.6K and bringing the position to 14,563 shares worth $915K. The position accounts for 0.01% of the portfolio, ranked #677.

Horizon Investments first reported a position in DXCM in Q2 2020 and has held it in 23 quarters since. The position peaked at $1.58M in Q4 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Horizon Investments held 14,563 shares of DexCom worth $915K as of Q1 2026.
  • Horizon Investments bought 196 DexCom shares in Q1 2026, an estimated $13.6K.
  • DexCom made up 0.01% of Horizon Investments's portfolio in Q1 2026, its #677 holding.
  • Horizon Investments first reported a position in DexCom in Q2 2020 and has held it in 23 quarters since.
  • Horizon Investments's DexCom position peaked at $1.58M in Q4 2021.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.